NV MEDTECH, Inc.

RENO, NV · Founded 2021 · CIK 0002139273 · Medtech · Private

Flow diversion device for treating brain aneurysms

nvmedtech.net →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$21M
1 Form D · Jun 2026
4 months since last filing
Contracts
—
No federal contracts on record
Patents
8
1 granted · 7 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$20,890,275
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1603UNPLUGS HEARING, INC.—$225K
1604HILLMED INC——
1605Acurion, Inc.—$4.1M
1606NV MEDTECH, Inc.—$21M
1607Emblok, Inc.—$6.0M
1608CereVu Medical, Inc.——
1609TREYSTA MEDICAL TECHNOLOGIES INC—$183K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Jeffrey EstesExecutive Officer
  • William KellyDirector
  • Christopher MartinDirector
  • George WallaceDirector · Executive Officer

Patents

USPTO · 1 granted of 8
  • Methods And Apparatus For Stent Assisted Aneurysm Coilingapplication
  • Methods And Apparatus For Stent Assisted Aneurysm Coilinggranted
  • Intravascular Flow Diverter And Related Methodsapplication
  • Intrasacular Flow Diverter And Related Methodsapplication
  • Intrasacular Flow Diverter And Related Methodsapplication
  • Methods And Systems For Stent Assisted Aneurysm Coilingapplication
  • Intravascular Flow Diverter And Related Methodsapplication
  • Methods And Apparatus For Aneurysm Treatmentapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.